Klein Lawrence Otto — SEC Form 4 filings
SEC reporting owner CIK 1762583. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2025-01-24 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 80,910 shares, $7,314,067 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 63,596 shares @ $91.90 ($5,844,237) in Oruka Therapeutics, Inc., filed 2026-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Executive Officer, Director | 6 | — | 6 legs · 80,910 sh · $7,314,067 | 5 |
| Jade Biosciences, Inc. (JBIO) | Director | 2 | — | — | 2 |
Form 4 filings — Klein Lawrence Otto
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 2,452 @ $95.71 | EDGAR |
| 2026-09-01 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 75,000 @ $7.80 · Sale (S): 6,604 @ $90.79 · Sale (S): 63,596 @ $91.90 · Sale (S): 4,800 @ $92.44 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 1,729 @ $69.69 | EDGAR |
| 2026-06-11 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 1,729 @ $41.30 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 76,700 @ $0 · Grant/award (A): 306,700 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1762583 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →